Cardiovascular revascularization medicine : including molecular interventions
-
Cardiovasc Revasc Med · Sep 2017
Review Meta AnalysisBivalirudin versus heparin in women undergoing percutaneous coronary intervention: A systematic review and meta-analysis of randomized clinical trials.
The anticoagulant of choice during percutaneous coronary intervention (PCI) in women is not well established. ⋯ In women undergoing PCI, bivalirudin is associated with reduced risk of major bleeding and NACE compared with heparin especially when GPI is routinely used.
-
Cardiovasc Revasc Med · Sep 2017
Case ReportsTranscatheter closure of a complex atrial septal defect after occluder device embolization.
Percutaneous closure is nowadays considered the treatment of choice of ostium secundum atrial septal defects (ASD). However, transcatheter closure can be highly challenging when we face an ASD with complex morphological features. The combination of different imaging modalities can be very helpful. This case shows the great value of using both intracardiac and real time 3D transesophageal echocardiography for the percutaneous closure of a complex iatrogenic ASD after device embolization.